Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Diagnostic Microbiology and Infectious Disease
|
July 1, 1990
Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values
K E Aldridge, L S Weeks, C W Stratton, et al.
American Journal of Clinical Pathology
|
August 1, 1985
Falsely elevated serum creatinine levels secondary to the presence of 5-fluorocytosine
R T Mitchell, L H Marshall, L B Lefkowitz, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1995
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa
J M Hyatt, D E Nix, C W Stratton, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome
M D Appleman, C E Cherubin, P N Heseltine, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1989
Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms
K E Aldridge, L S Weeks, C W Stratton, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1997
High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin
S J Antony, J Ladner, C W Stratton, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1985
Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa
F Tausk, M E Evans, L S Patterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1995
Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae
D W Haas, C W Stratton, J P Griffin, et al.
The American Journal of Medicine
|
August 1, 1987
Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis
M P Weinstein, C W Stratton, H B Hawley, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 2, 2001
Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens
S Y Yao, A Ljunggren-Rose, C W Stratton, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Diagnostic Microbiology and Infectious Disease
|
July 1, 1990
Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values
K E Aldridge, L S Weeks, C W Stratton, et al.
American Journal of Clinical Pathology
|
August 1, 1985
Falsely elevated serum creatinine levels secondary to the presence of 5-fluorocytosine
R T Mitchell, L H Marshall, L B Lefkowitz, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1995
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa
J M Hyatt, D E Nix, C W Stratton, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome
M D Appleman, C E Cherubin, P N Heseltine, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1989
Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms
K E Aldridge, L S Weeks, C W Stratton, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1997
High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin
S J Antony, J Ladner, C W Stratton, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1985
Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa
F Tausk, M E Evans, L S Patterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1995
Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae
D W Haas, C W Stratton, J P Griffin, et al.
The American Journal of Medicine
|
August 1, 1987
Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis
M P Weinstein, C W Stratton, H B Hawley, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 2, 2001
Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens
S Y Yao, A Ljunggren-Rose, C W Stratton, et al.
Page
of 12